Assessing pathological response to neoadjuvant therapy in renal cell carcinoma: a systematic review and guidelines for sampling and reporting standards from the International Neoadjuvant Kidney Cancer Consortium

James P. Blackmur, J C Koen van der Mijn, Anne Y. Warren, Lisa Browning, Femke Burgers, Michelle S. Hirsch, Payal Kapur, Rohit Mehra, Priya Rao, Sabina Signoretti, Axel Bex, Grant D. Stewart, Maurits L. van Montfoort, James O. Jones, Jason E. Abel, Laurence Albigès, Jens Bedke, Karim Bensalah, Stephanie Berg, Jean‐Christophe Bernhard, Gennady Bratslavsky, David Braun, Janet Brown, James Brugarolas, Femke Burgers, Riccardo Campi, Umberto Capitanio, Toni K. Choueiri, Antonio Finelli, Andrew Furness, Ferdia A. Gallagher, Daniel J. George, Niels M. Graafland, John B.A.G. Haanen, Naomi B. Haas, A. Ari Hakimi, Hans J. Hammers, Will Ince, Michael A.S. Jewett, Eric Jonasch, Payal Kapur, Alexander Laird, Bryan Lewis, Marston Linehan, Viraj A. Master, Bradley A. McGregor, Rana R. McKay, Arnaud Méjean, Tom Mitchell, Robert J. Motzer, David Nicol, Grenville Oades, Brent O’Carrigan, Sumanta Pal, Phillip M. Pierorazio, Susan Poteat, Thomas Powles, Andrew Protheroe, W. Kimryn Rathmell, Brian Rini, Sabrina H. Rossi, Antonio Rullan, Daniel D. Shapiro, Scott Shepherd, Eric A. Singer, Shankar Siva, Chuck Stravin, Cristina Suárez, M. Sullivan, Nizar Tannir, Zayd Tippu, Samra Turajlic, Mark Tuthill, Robert G. Uzzo, Ulka N. Vaishampayan, Balaji Venugopal, Martin Voß, Christof Vulsteke, Tom Waddell, James Wason, Vincent Xu